Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE

J Transl Med. 2024 May 13;22(1):449. doi: 10.1186/s12967-024-05275-8.

Abstract

Inherited deficiency of thymidine phosphorylase (TP), encoded by TYMP, leads to a rare disease with multiple mitochondrial DNA (mtDNA) abnormalities, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). However, the impact of TP deficiency on lysosomes remains unclear, which are important for mitochondrial quality control and nucleic acid metabolism. Muscle biopsy tissue and skin fibroblasts from MNGIE patients, patients with m.3243 A > G mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) and healthy controls (HC) were collected to perform mitochondrial and lysosomal functional analyses. In addition to mtDNA abnormalities, compared to controls distinctively reduced expression of LAMP1 and increased mitochondrial content were detected in the muscle tissue of MNGIE patients. Skin fibroblasts from MNGIE patients showed decreased expression of LAMP2, lowered lysosomal acidity, reduced enzyme activity and impaired protein degradation ability. TYMP knockout or TP inhibition in cells can also induce the similar lysosomal dysfunction. Using lysosome immunoprecipitation (Lyso- IP), increased mitochondrial proteins, decreased vesicular proteins and V-ATPase enzymes, and accumulation of various nucleosides were detected in lysosomes with TP deficiency. Treatment of cells with high concentrations of dThd and dUrd also triggers lysosomal dysfunction and disruption of mitochondrial homeostasis. Therefore, the results provided evidence that TP deficiency leads to nucleoside accumulation in lysosomes and lysosomal dysfunction, revealing the widespread disruption of organelles underlying MNGIE.

Keywords: Lysosomal dysfunction; MNGIE; Nucleotide metabolism; TYMP; Thymidine phosphorylase.

MeSH terms

  • DNA, Mitochondrial* / genetics
  • DNA, Mitochondrial* / metabolism
  • Female
  • Fibroblasts* / metabolism
  • Fibroblasts* / pathology
  • Humans
  • Intestinal Pseudo-Obstruction / enzymology
  • Intestinal Pseudo-Obstruction / genetics
  • Intestinal Pseudo-Obstruction / metabolism
  • Intestinal Pseudo-Obstruction / pathology
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Lysosomes* / metabolism
  • Male
  • Mitochondria* / metabolism
  • Mitochondrial Encephalomyopathies* / genetics
  • Mitochondrial Encephalomyopathies* / metabolism
  • Mitochondrial Encephalomyopathies* / pathology
  • Muscular Dystrophy, Oculopharyngeal / metabolism
  • Muscular Dystrophy, Oculopharyngeal / pathology
  • Nucleosides* / metabolism
  • Ophthalmoplegia / congenital
  • Ophthalmoplegia / metabolism
  • Ophthalmoplegia / pathology
  • Skin / metabolism
  • Skin / pathology
  • Thymidine Phosphorylase* / deficiency
  • Thymidine Phosphorylase* / genetics
  • Thymidine Phosphorylase* / metabolism

Substances

  • Thymidine Phosphorylase
  • DNA, Mitochondrial
  • Nucleosides
  • Lysosomal-Associated Membrane Protein 2

Supplementary concepts

  • Visceral myopathy familial external ophthalmoplegia